Impact of a hyperglycemic crises protocol

Endocrine Practice

Volumn 19, Issue 6, 2013, Pages 953-962

  Hara, Jayme ^a,b   Rahbar, Aryan ^b   Jeffres, Meghan ^b,c,d   Izuora, Kenneth ^d  

^a METHODIST UNIVERSITY HOSPITAL   (United States)

^b University Medical Center of Southern Nevada   (United States)

^c ROSEMAN UNIVERSITY OF HEALTH SCIENCES   (United States)

^d UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE; GLUCOSE; INFUSION FLUID; INSULIN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERGLYCEMIC CRISES PROTOCOL; HYPEROSMOLAR HYPERGLYCEMIC STATE; HYPOGLYCEMIA; HYPOKALEMIA; INSULIN INFUSION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; OUTCOME ASSESSMENT; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; CLINICAL PROTOCOLS; COMORBIDITY; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC COMA; DIABETIC KETOACIDOSIS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOSPITALS, UNIVERSITY; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; HYPOKALEMIA; INFUSIONS, INTRAVENOUS; INSULIN; INTENSIVE CARE UNITS; LONGEVITY; MALE; MIDDLE AGED; PATIENT SAFETY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84888870295     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP13077.OR     Document Type: Article

References (14)

1. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Diabetes Surveillance System. Number (in Thousands) of Hospital Discharges with Diabetic Ketoacidosis as First-Listed Diagnosis, United States, 1988-2009. Available at: http://www.cdc.gov/diabetes/ statistics/dkafirst/fig1.htm. Accessed June 3, 2013.
2. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Diabetes Surveillance System. Number of Deaths for Hyperglycemic Crisis as Underlying Cause, United States, 1980-2009. Available at: http://www.cdc.gov/diabetes/statistics/mortalitydka/fNumberOfDKA. htm. Accessed June 3, 2013.
3. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic Crises in Adult Patients with Diabetes. Diabetes Care. 2009;32:1335-1343.
4. Singh RK, Perros P, Frier BM. Hospital management of diabetic ketoacidosis: are clinical guidelines implemented effectively? Diabet Med. 1997;14:482-486.
5. Solá E, Garzón S, García-Torres S, Cubells P, Morillas C, Hernández-Mijares A. Management of diabetic ketoacidosis in a teaching hospital. Acta Diabetol. 2006;43: 127-130.
6. Devalia B. Adherence to protocol during the acute management of diabetic ketoacidosis: would specialist involvement lead to better outcomes? Int J Clin Pract. 2010;64: 1580-1582.
7. Bull SV, Douglas IS, Foster M, Albert RK. Mandatory protocol for treating adult patients with diabetic ketoacidosis decreases intensive care unit and hospital lengths of stay: results of a nonrandomized trial. Crit Care Med. 2007; 35:41-46.
8. Ilag LL, Kronick S, Ernst RD, et al. Impact of a critical pathway on inpatient management of diabetic ketoacidosis. Diabetes Res Clin Pract. 2003;62:23-32.
9. Waller SL, Delaney S, Strachan MW. Does an integrated care pathway enhance the management of diabetic ketoacidosis? Diabet Med. 2007;24:359-363.
10. Kitabchi AE, Umiperrez GE, Murphy MB, et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care. 2001;24:131-153.
11. Chiasson JL, Aris-Jilwan N, Bélanger R, et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ. 2003;168:859-866.
12. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion. Diabetes Surveillance System. Average Length of Stay (LOS) in Days of Hospital Discharge with Diabetes Ketoacidosis as First-Listed Diagnosis, United States, 1988-2009. Available at: http://www.cdc.gov/diabetes/statistics/dkafirst/fig2.htm. Accessed June 3, 2013.
13. Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, Ellis SE, O'Sullivan PS. Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island. J Gen Intern Med. 1991;6:495-502.
14. Matz R. Management of the hyperosmolar hyperglycemic syndrome. Am Fam Physician. 1999;60:1468-1476.